SCHEMBL28654053

SCHEMBL28654053

O=COCc1[nH]c2ccc(Br)cc2c1C=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.40
PIM3 Q86V86 1/20 0.40
SIRT1 Q96EB6 1/20 0.39
LMNA P02545 2/20 0.38
HPGD P15428 1/20 0.38
GSK3B P49841 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
PRNP P04156 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PPARG P37231 1/20 0.36
HIF1A Q16665 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NR2E3 Q9Y5X4 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7824030 0.76 SIRT1 (0.40) PIM1PIM3SIRT1LMNAHPGD
SCHEMBL27810837 0.72 SIRT1 (0.37) PIM1PIM3SIRT1LMNAHPGD
SCHEMBL28460398 0.72 PIM1 (0.46) PIM1PIM3LMNAHPGDGSK3B
SCHEMBL29951828 0.72 PIM1 (0.46) PIM1PIM3LMNAHPGDGSK3B
SCHEMBL16920112 0.72 PIM1 (0.46) PIM1PIM3LMNAHPGDGSK3B
SCHEMBL3198006 0.72 LMNA (0.51) PIM1PIM3LMNAHPGDGSK3B
SCHEMBL29954657 0.69 LMNA (0.44) PIM1PIM3LMNAHPGDGSK3B
SCHEMBL29951788 0.69 HPGD (0.44) PIM1PIM3LMNAHPGDGSK3B
SCHEMBL29955514 0.69 RXFP1 (0.58) PIM1PIM3SIRT1LMNAGSK3B
SCHEMBL29957448 0.68 CYP2D6 (0.42) PIM1PIM3SIRT1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113646050-A Thieno [3,2-B ] pyrrolo [3,2-D ] pyridazinone derivatives and their use as PKM2 derivatives for the treatment of cancer, obesity and diabetes related disorders 安吉奥斯医药品有限公司 2021-11-12 CN disclosed